APA (7th ed.) Citation

XF, Y., SW, S., & K, C. (2023). Case report: Recombinant human epidermal growth factor gel plus kangfuxin solution in the treatment of aplasia cutis congenita in a case with Adams-Oliver syndrome. Frontiers in surgery, 9, 1072021. https://doi.org/10.3389/fsurg.2022.1072021

Chicago Style (17th ed.) Citation

XF, Yang, Shi SW, and Chen K. "Case Report: Recombinant Human Epidermal Growth Factor Gel Plus Kangfuxin Solution in the Treatment of Aplasia Cutis Congenita in a Case with Adams-Oliver Syndrome." Frontiers in Surgery 9 (2023): 1072021. https://doi.org/10.3389/fsurg.2022.1072021.

MLA (9th ed.) Citation

XF, Yang, et al. "Case Report: Recombinant Human Epidermal Growth Factor Gel Plus Kangfuxin Solution in the Treatment of Aplasia Cutis Congenita in a Case with Adams-Oliver Syndrome." Frontiers in Surgery, vol. 9, 2023, p. 1072021, https://doi.org/10.3389/fsurg.2022.1072021.